Literature DB >> 8227413

Detection of immunoglobulin heavy chain gene rearrangements in Hodgkin's disease using PCR.

C A Angel1, J H Pringle, L Primrose, I Lauder.   

Abstract

AIM: To detect clonal rearrangements of the immunoglobulin (Ig) heavy chain gene in Hodgkin's disease tissue using the polymerase chain reaction (PCR).
METHODS: DNA extracted from 36 samples of Hodgkin's disease was analysed using PCR and primers from conserved sequences in the variable (VH) and joining (JH) regions.
RESULTS: Clonal rearrangement was detected only in one case. Evidence of clonal immunoglobulin gene rearrangement had been detected previously in this case using conventional Southern blot analysis.
CONCLUSIONS: The sensitivity of the two techniques is equivalent and clonal Ig heavy chain gene rearrangements are rare in Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227413      PMCID: PMC501623          DOI: 10.1136/jcp.46.10.940

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

Review 1.  The clinical significance of antigen receptor gene rearrangements in lymphoid neoplasia.

Authors:  J Sklar; J Longtine
Journal:  Cancer       Date:  1992-09-15       Impact factor: 6.860

2.  Polyclonal rearrangement of the T-cell antigen receptor genes in Hodgkin's disease: implications for diagnosis.

Authors:  J O Jacobson; B M Wilkes; N L Harris
Journal:  Mod Pathol       Date:  1991-03       Impact factor: 7.842

3.  Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens.

Authors:  K P McCarthy; J P Sloane; L M Wiedemann
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

4.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

5.  Clonal immunoglobulin gene rearrangements in tissues involved by Hodgkin's disease.

Authors:  M G Brinker; S Poppema; C H Buys; W Timens; J Osinga; L Visser
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

6.  Immunoglobulin gene rearrangements in Hodgkin's disease.

Authors:  L M Weiss; J G Strickler; E Hu; R A Warnke; J Sklar
Journal:  Hum Pathol       Date:  1986-10       Impact factor: 3.466

7.  Analysis of antigen receptor genes in Hodgkin's disease.

Authors:  C A Angel; J H Pringle; J Naylor; K P West; I Lauder
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

8.  The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection.

Authors:  L S Young; I S Bevan; M A Johnson; P I Blomfield; T Bromidge; N J Maitland; C B Woodman
Journal:  BMJ       Date:  1989-01-07

9.  Karyotypic abnormalities and immunoglobulin gene rearrangements in Hodgkin's disease.

Authors:  R E Banks; S Gledhill; F M Ross; A Krajewski; A E Dewar; E M Weir-Thompson
Journal:  Cancer Genet Cytogenet       Date:  1991-01

10.  Lack of TdT and immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease.

Authors:  A Villa; G Cairo; M R Pozzi; L Schiaffonati; L Bardella; R Lucchini; D Delia; C Besana; I Biunno; P Vezzoni
Journal:  Int J Biol Markers       Date:  1987 May-Aug       Impact factor: 3.248

View more
  3 in total

1.  Angiotropic lymphoma: report of a case with histiocytic features.

Authors:  J A Snowden; C A Angel; D A Winfield; J H Pringle; K P West
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

2.  Poor correlation between clonal immunoglobulin gene rearrangement and immunoglobulin gene transcription in Hodgkin's disease.

Authors:  Y Yatabe; K Oka; J Asai; N Mori
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

3.  PCR clonality detection in Hodgkin lymphoma.

Authors:  K M Hebeda; M C Van Altena; P Rombout; J H J M Van Krieken; P J T A Groenen
Journal:  J Hematop       Date:  2009-02-20       Impact factor: 0.196

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.